BIO5 member Joanna Masel, senior author of a PNAS study, led research challenging the understanding of genetic code evolution. The team discovered earlier genetic codes evolved differently, revising key evolutionary assumptions.

BIO5 member Sairam Parthasarathy led a study showing peer support improves CPAP adherence and satisfaction in sleep apnea patients, increasing use to 4.5 hours/night. BIO5 members Stefano Guerra and Michael Grandner co-authored the study.

Phoenix-born Tej Desai grew his computational skills during the KEYS Research Internship to help him advance his goals of working at the intersection of medicine and innovation.

Over 20 researchers and innovators gathered in late October to learn about IP, patents, and start-ups.

Multiple BIO5 members play roles as mentors as a part of the University of Arizona's Integrative Cancer Scholars Program including: Clara Curiel-Lewandrowski , DongKyun Kang, Wei Wang, Jacob Schwartz, Gregory Rogers.

BIO5 member Heather Ingram is the newly appointed Museum Director at the Coit Museum of Pharmacy and Health Sciences. and aims to advance the museum's vision of creating an authentic and engaging experience that broadens perspectives about pharmacy and health sciences for everyone.

BIO5 member Floyd "Ski" Chilton is part of a research team investigating how ancestry and genetics shape the body's response to omega-3 fatty acids with a $3.9 million grant from the National Institutes of Health.

A large and generous collection of artwork donated by the family of the late Marvin Lowe was added to buildings of BIO5 Institute earlier this year.

BIO5 member Christopher Glembotski at University of Arizona College of Medicine-Phoenix is studying the molecular basis of heart disease to develop new treatments. His work, funded by a $2.8M NIH grant, could revolutionize heart disease care globally.

BIO5 members Lalitha Madhavan and Robin Polt are part of a group of researchers who published a study finding that a tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson’s disease and related disorders.